Core Viewpoint - The legal opinion letter confirms that the third extraordinary general meeting of shareholders of Blu-ray Medical Co., Ltd. was convened and conducted in compliance with relevant laws, regulations, and the company's articles of association [1][6]. Group 1: Meeting Procedures - The notice for the third extraordinary general meeting included details such as the convener, date, time, method of holding the meeting, and voting procedures [2][3]. - The meeting was held on August 14, 2025, at the specified location and was presided over by the chairman [3][4]. - The meeting utilized a combination of on-site and online voting, with specific time frames for each voting method [3][4]. Group 2: Attendance and Qualifications - The meeting was convened by the company's board of directors, and a total of 12 shareholders attended the meeting in person, representing 296,063,301 shares, which is 29.3967% of the total shares [4][5]. - Additionally, 593 shareholders participated via online voting, representing 20,681,757 shares [4][5]. - The qualifications of the convener and attendees were verified and deemed valid according to legal requirements [5][6]. Group 3: Resolutions and Voting Results - The agenda included a proposal to adjust the conversion price of "Blu-ray Convertible Bonds," which was consistent with the notice sent to shareholders [5][6]. - The voting results showed that 301,275,562 shares approved the proposal, with 78.5309% of minority investors voting in favor [5][6].
蓝帆医疗: 上海锦天城(青岛)律师事务所关于蓝帆医疗股份有限公司2025年第三次临时股东会的法律意见书